Victrelis
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The US Food and Drug Administration (FDA) approvals of Gilead’s Sovaldi (sofosbuvir) on December 6 and, to a lesser extent, of…
The Hepatitis C virus infects an estimated 170 million people worldwide, and is the major cause of hepatitis, cirrhosis and liver…
Merck & Co. and Roche, two rivals in the hepatitis C virus (HCV) market, have joined forces in a broad, non-exclusive…
for people on Victrelis-based triple therapy. But the newly approved drugs also have major shortcomings, adding an extra safety…
Following approval of hepatitis C virus protease inhibitors Incivek and Victrelis, companies are partnering to devise all-oral…
Chronic viral hepatitis B and C are a significant cause of chronic liver disease worldwide and still represent a pathology…